[{"edinetCode":"E00944","endDate":"2017\/2\/28","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":2751.0,"averageTemporaryStaff":630.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":36136000.0,"sharesOwendPercent":0.3797,"outstandingShares":null,"numberOfSubsidiary":16.0,"bps":2724.0,"equityRatio":0.817,"cashAndCashEquivalents":105610000000.0,"assets":278820000000.0,"currentAssets":172097000000.0,"fixedAsset":106722000000.0,"tangibleFixedAssets":43031000000.0,"intangibleFixedAssets":5973000000.0,"investmentAndOtherAssets":57718000000.0,"liabilities":49614000000.0,"currentLiabilities":32425000000.0,"shorTermDept":1561000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":17189000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":576000000.0,"netAsset":229205000000.0,"capitalStock":203897000000.0,"capital":8473000000.0,"capitalSurplus":5914000000.0,"accumulatedEarnings":224214000000.0,"treasuryStock":-34705000000.0,"valuationAndConversionAdjustments":24007000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":145925000000.0,"costOfSales":53155000000.0,"grossProfit":92770000000.0,"sgaExpenses":66464000000.0,"salaryAndBenefit":8553000000.0,"depreciationAndSGA":null,"RDExpenses":14378000000.0,"operatingIncome":26306000000.0,"nonOperatingIncome":2034000000.0,"nonOperatingExpenses":160000000.0,"interestExpense":39000000.0,"ordinaryProfit":28179000000.0,"extraordinaryGain":4231000000.0,"extraordinaryLoss":2426000000.0,"incomeBeforeTax":29984000000.0,"incomeTaxes":9443000000.0,"netIncome":20541000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":20395000000.0,"comprehensiveIncome":21156000000.0,"eps":241.27,"dilutedEps":241.15,"dividendPerShare":null,"per":25.0,"roe":0.09,"cashFlowFromOperatingActivities":19910000000.0,"depreciationAndCashflowFromOperatingActivities":6438000000.0,"cashFlowFromInvestingActivities":1070000000.0,"cashFlowFromFinancialActivities":-18402000000.0,"changesInCashAndCashEquivalents":1669000000.0,"列1":"asr","submitDate":"2017\/5\/26","stockCode":4530,"accountingYear":"第115期(自　平成28年３月１日　至　平成29年２月28日)","accountingYearStart":"2016\/3\/1","accountingYearEnd":"2017\/2\/28","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00944","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":8473,"settlementDate":null,"submitterName":"久光製薬株式会社","submitterNameEnglish":"HISAMITSU PHARMACEUTICAL CO.,INC.","submitterNameKana":"ヒサミツセイヤクカブシキガイシャ","location":"鳥栖市田代大官町４０８番地","industory":"医薬品","corporateNumber":7300000000000.0},{"edinetCode":"E00944","endDate":"2018\/2\/28","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":2823.0,"averageTemporaryStaff":899.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":36474000.0,"sharesOwendPercent":0.3833,"outstandingShares":null,"numberOfSubsidiary":18.0,"bps":2912.83,"equityRatio":0.813,"cashAndCashEquivalents":126569000000.0,"assets":299913000000.0,"currentAssets":190065000000.0,"fixedAsset":109847000000.0,"tangibleFixedAssets":40064000000.0,"intangibleFixedAssets":4100000000.0,"investmentAndOtherAssets":65683000000.0,"liabilities":54686000000.0,"currentLiabilities":34938000000.0,"shorTermDept":1461000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":19747000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":504000000.0,"netAsset":245227000000.0,"capitalStock":216021000000.0,"capital":8473000000.0,"capitalSurplus":5914000000.0,"accumulatedEarnings":236342000000.0,"treasuryStock":-34709000000.0,"valuationAndConversionAdjustments":27679000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":147870000000.0,"costOfSales":55688000000.0,"grossProfit":92182000000.0,"sgaExpenses":65836000000.0,"salaryAndBenefit":7598000000.0,"depreciationAndSGA":null,"RDExpenses":15076000000.0,"operatingIncome":26345000000.0,"nonOperatingIncome":2398000000.0,"nonOperatingExpenses":498000000.0,"interestExpense":32000000.0,"ordinaryProfit":28245000000.0,"extraordinaryGain":487000000.0,"extraordinaryLoss":1038000000.0,"incomeBeforeTax":27694000000.0,"incomeTaxes":8367000000.0,"netIncome":19327000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":19119000000.0,"comprehensiveIncome":22852000000.0,"eps":228.52,"dilutedEps":228.35,"dividendPerShare":null,"per":33.9,"roe":0.081,"cashFlowFromOperatingActivities":30453000000.0,"depreciationAndCashflowFromOperatingActivities":6005000000.0,"cashFlowFromInvestingActivities":-1378000000.0,"cashFlowFromFinancialActivities":-7153000000.0,"changesInCashAndCashEquivalents":20959000000.0,"列1":"asr","submitDate":"2018\/5\/25","stockCode":4530,"accountingYear":"第116期(自　平成29年３月１日　至　平成30年２月28日)","accountingYearStart":"2017\/3\/1","accountingYearEnd":"2018\/2\/28","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00944","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":8473,"settlementDate":null,"submitterName":"久光製薬株式会社","submitterNameEnglish":"HISAMITSU PHARMACEUTICAL CO.,INC.","submitterNameKana":"ヒサミツセイヤクカブシキガイシャ","location":"鳥栖市田代大官町４０８番地","industory":"医薬品","corporateNumber":7300000000000.0},{"edinetCode":"E00944","endDate":"2019\/2\/28","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":2792.0,"averageTemporaryStaff":636.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":36352000.0,"sharesOwendPercent":0.4396,"outstandingShares":null,"numberOfSubsidiary":18.0,"bps":2981.63,"equityRatio":0.828,"cashAndCashEquivalents":88782000000.0,"assets":297512000000.0,"currentAssets":193569000000.0,"fixedAsset":103942000000.0,"tangibleFixedAssets":39556000000.0,"intangibleFixedAssets":1990000000.0,"investmentAndOtherAssets":62394000000.0,"liabilities":49350000000.0,"currentLiabilities":30354000000.0,"shorTermDept":1361000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":18996000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":433000000.0,"netAsset":248161000000.0,"capitalStock":222189000000.0,"capital":8473000000.0,"capitalSurplus":5914000000.0,"accumulatedEarnings":248687000000.0,"treasuryStock":-40886000000.0,"valuationAndConversionAdjustments":24284000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":143408000000.0,"costOfSales":54727000000.0,"grossProfit":88680000000.0,"sgaExpenses":66401000000.0,"salaryAndBenefit":7796000000.0,"depreciationAndSGA":null,"RDExpenses":13032000000.0,"operatingIncome":22278000000.0,"nonOperatingIncome":2582000000.0,"nonOperatingExpenses":214000000.0,"interestExpense":19000000.0,"ordinaryProfit":24647000000.0,"extraordinaryGain":1312000000.0,"extraordinaryLoss":285000000.0,"incomeBeforeTax":25673000000.0,"incomeTaxes":6294000000.0,"netIncome":19378000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":19204000000.0,"comprehensiveIncome":15969000000.0,"eps":230.08,"dilutedEps":229.86,"dividendPerShare":null,"per":23.9,"roe":0.078,"cashFlowFromOperatingActivities":15772000000.0,"depreciationAndCashflowFromOperatingActivities":5742000000.0,"cashFlowFromInvestingActivities":-39302000000.0,"cashFlowFromFinancialActivities":-13347000000.0,"changesInCashAndCashEquivalents":-37786000000.0,"列1":"asr","submitDate":"2019\/5\/27","stockCode":4530,"accountingYear":"第117期(自　2018年３月１日　至　2019年２月28日)","accountingYearStart":"2018\/3\/1","accountingYearEnd":"2019\/2\/28","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00944","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":8473,"settlementDate":null,"submitterName":"久光製薬株式会社","submitterNameEnglish":"HISAMITSU PHARMACEUTICAL CO.,INC.","submitterNameKana":"ヒサミツセイヤクカブシキガイシャ","location":"鳥栖市田代大官町４０８番地","industory":"医薬品","corporateNumber":7300000000000.0},{"edinetCode":"E00944","endDate":"2019\/5\/31","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.832,"cashAndCashEquivalents":null,"assets":290121000000.0,"currentAssets":192461000000.0,"fixedAsset":97660000000.0,"tangibleFixedAssets":39100000000.0,"intangibleFixedAssets":1867000000.0,"investmentAndOtherAssets":56692000000.0,"liabilities":46817000000.0,"currentLiabilities":31490000000.0,"shorTermDept":1320000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":15327000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":420000000.0,"netAsset":243303000000.0,"capitalStock":221159000000.0,"capital":8473000000.0,"capitalSurplus":5914000000.0,"accumulatedEarnings":247659000000.0,"treasuryStock":-40887000000.0,"valuationAndConversionAdjustments":20364000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":29233000000.0,"costOfSales":10901000000.0,"grossProfit":18331000000.0,"sgaExpenses":15552000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":2778000000.0,"nonOperatingIncome":453000000.0,"nonOperatingExpenses":368000000.0,"interestExpense":3000000.0,"ordinaryProfit":2863000000.0,"extraordinaryGain":null,"extraordinaryLoss":1000000.0,"incomeBeforeTax":2862000000.0,"incomeTaxes":887000000.0,"netIncome":1974000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":1913000000.0,"comprehensiveIncome":-1933000000.0,"eps":23.15,"dilutedEps":23.13,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2019\/7\/11","stockCode":4530,"accountingYear":null,"accountingYearStart":"2019\/3\/1","accountingYearEnd":"2020\/2\/29","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00944","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":8473,"settlementDate":null,"submitterName":"久光製薬株式会社","submitterNameEnglish":"HISAMITSU PHARMACEUTICAL CO.,INC.","submitterNameKana":"ヒサミツセイヤクカブシキガイシャ","location":"鳥栖市田代大官町４０８番地","industory":"医薬品","corporateNumber":7300000000000.0},{"edinetCode":"E00944","endDate":"2019\/8\/31","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":35385000.0,"sharesOwendPercent":0.4295,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.819,"cashAndCashEquivalents":86345000000.0,"assets":296731000000.0,"currentAssets":200319000000.0,"fixedAsset":96411000000.0,"tangibleFixedAssets":38936000000.0,"intangibleFixedAssets":1688000000.0,"investmentAndOtherAssets":55786000000.0,"liabilities":51911000000.0,"currentLiabilities":36708000000.0,"shorTermDept":1282000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":15202000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":405000000.0,"netAsset":244820000000.0,"capitalStock":225515000000.0,"capital":8473000000.0,"capitalSurplus":5914000000.0,"accumulatedEarnings":253293000000.0,"treasuryStock":-42166000000.0,"valuationAndConversionAdjustments":17490000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":63401000000.0,"costOfSales":22892000000.0,"grossProfit":40509000000.0,"sgaExpenses":30319000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":5330000000.0,"operatingIncome":10190000000.0,"nonOperatingIncome":1182000000.0,"nonOperatingExpenses":730000000.0,"interestExpense":8000000.0,"ordinaryProfit":10641000000.0,"extraordinaryGain":null,"extraordinaryLoss":4000000.0,"incomeBeforeTax":10637000000.0,"incomeTaxes":2955000000.0,"netIncome":7681000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":7548000000.0,"comprehensiveIncome":887000000.0,"eps":91.37,"dilutedEps":91.27,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":7913000000.0,"depreciationAndCashflowFromOperatingActivities":2025000000.0,"cashFlowFromInvestingActivities":-4655000000.0,"cashFlowFromFinancialActivities":-4880000000.0,"changesInCashAndCashEquivalents":-2436000000.0,"列1":"q2r","submitDate":"2019\/10\/11","stockCode":4530,"accountingYear":null,"accountingYearStart":"2019\/3\/1","accountingYearEnd":"2020\/2\/29","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00944","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":8473,"settlementDate":null,"submitterName":"久光製薬株式会社","submitterNameEnglish":"HISAMITSU PHARMACEUTICAL CO.,INC.","submitterNameKana":"ヒサミツセイヤクカブシキガイシャ","location":"鳥栖市田代大官町４０８番地","industory":"医薬品","corporateNumber":7300000000000.0},{"edinetCode":"E00944","endDate":"2019\/11\/30","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.806,"cashAndCashEquivalents":null,"assets":307986000000.0,"currentAssets":205531000000.0,"fixedAsset":102455000000.0,"tangibleFixedAssets":38695000000.0,"intangibleFixedAssets":1565000000.0,"investmentAndOtherAssets":62194000000.0,"liabilities":57738000000.0,"currentLiabilities":40685000000.0,"shorTermDept":1245000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":17053000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":388000000.0,"netAsset":250248000000.0,"capitalStock":226728000000.0,"capital":8473000000.0,"capitalSurplus":2272000000.0,"accumulatedEarnings":227712000000.0,"treasuryStock":-11730000000.0,"valuationAndConversionAdjustments":21636000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":99078000000.0,"costOfSales":34554000000.0,"grossProfit":64523000000.0,"sgaExpenses":46106000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":18417000000.0,"nonOperatingIncome":1729000000.0,"nonOperatingExpenses":229000000.0,"interestExpense":13000000.0,"ordinaryProfit":19917000000.0,"extraordinaryGain":1610000000.0,"extraordinaryLoss":10000000.0,"incomeBeforeTax":21518000000.0,"incomeTaxes":5921000000.0,"netIncome":15597000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":15420000000.0,"comprehensiveIncome":12949000000.0,"eps":187.36,"dilutedEps":187.14,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2020\/1\/10","stockCode":4530,"accountingYear":null,"accountingYearStart":"2019\/3\/1","accountingYearEnd":"2020\/2\/29","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00944","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":8473,"settlementDate":null,"submitterName":"久光製薬株式会社","submitterNameEnglish":"HISAMITSU PHARMACEUTICAL CO.,INC.","submitterNameKana":"ヒサミツセイヤクカブシキガイシャ","location":"鳥栖市田代大官町４０８番地","industory":"医薬品","corporateNumber":7300000000000.0},{"edinetCode":"E00944","endDate":"2020\/2\/29","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":2745.0,"averageTemporaryStaff":728.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":36390000.0,"sharesOwendPercent":0.4455,"outstandingShares":null,"numberOfSubsidiary":18.0,"bps":3046.45,"equityRatio":0.809,"cashAndCashEquivalents":86996000000.0,"assets":307401000000.0,"currentAssets":209251000000.0,"fixedAsset":98150000000.0,"tangibleFixedAssets":38596000000.0,"intangibleFixedAssets":1469000000.0,"investmentAndOtherAssets":58083000000.0,"liabilities":56654000000.0,"currentLiabilities":41055000000.0,"shorTermDept":1209000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":15598000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":368000000.0,"netAsset":250746000000.0,"capitalStock":229945000000.0,"capital":8473000000.0,"capitalSurplus":2272000000.0,"accumulatedEarnings":230929000000.0,"treasuryStock":-11730000000.0,"valuationAndConversionAdjustments":18838000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":140992000000.0,"costOfSales":53388000000.0,"grossProfit":87603000000.0,"sgaExpenses":64875000000.0,"salaryAndBenefit":7608000000.0,"depreciationAndSGA":null,"RDExpenses":10504000000.0,"operatingIncome":22727000000.0,"nonOperatingIncome":3165000000.0,"nonOperatingExpenses":264000000.0,"interestExpense":19000000.0,"ordinaryProfit":25628000000.0,"extraordinaryGain":1685000000.0,"extraordinaryLoss":1159000000.0,"incomeBeforeTax":26155000000.0,"incomeTaxes":7244000000.0,"netIncome":18911000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":18694000000.0,"comprehensiveIncome":13478000000.0,"eps":227.58,"dilutedEps":227.3,"dividendPerShare":null,"per":21.2,"roe":0.075,"cashFlowFromOperatingActivities":27395000000.0,"depreciationAndCashflowFromOperatingActivities":4251000000.0,"cashFlowFromInvestingActivities":-17229000000.0,"cashFlowFromFinancialActivities":-11726000000.0,"changesInCashAndCashEquivalents":-1786000000.0,"列1":"asr","submitDate":"2020\/5\/22","stockCode":4530,"accountingYear":"第118期(自　2019年３月１日　至　2020年２月29日)","accountingYearStart":"2019\/3\/1","accountingYearEnd":"2020\/2\/29","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00944","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":8473,"settlementDate":null,"submitterName":"久光製薬株式会社","submitterNameEnglish":"HISAMITSU PHARMACEUTICAL CO.,INC.","submitterNameKana":"ヒサミツセイヤクカブシキガイシャ","location":"鳥栖市田代大官町４０８番地","industory":"医薬品","corporateNumber":7300000000000.0},{"edinetCode":"E00944","endDate":"2020\/5\/31","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.834,"cashAndCashEquivalents":null,"assets":297085000000.0,"currentAssets":195780000000.0,"fixedAsset":101305000000.0,"tangibleFixedAssets":37973000000.0,"intangibleFixedAssets":1570000000.0,"investmentAndOtherAssets":61761000000.0,"liabilities":47376000000.0,"currentLiabilities":31046000000.0,"shorTermDept":1211000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":16329000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":349000000.0,"netAsset":249709000000.0,"capitalStock":226711000000.0,"capital":8473000000.0,"capitalSurplus":2284000000.0,"accumulatedEarnings":227653000000.0,"treasuryStock":-11699000000.0,"valuationAndConversionAdjustments":21147000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":24882000000.0,"costOfSales":9672000000.0,"grossProfit":15210000000.0,"sgaExpenses":14132000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":1078000000.0,"nonOperatingIncome":379000000.0,"nonOperatingExpenses":1040000000.0,"interestExpense":2000000.0,"ordinaryProfit":418000000.0,"extraordinaryGain":1000000.0,"extraordinaryLoss":0.0,"incomeBeforeTax":418000000.0,"incomeTaxes":334000000.0,"netIncome":84000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":113000000.0,"comprehensiveIncome":2333000000.0,"eps":1.39,"dilutedEps":1.39,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2020\/7\/10","stockCode":4530,"accountingYear":null,"accountingYearStart":"2020\/3\/1","accountingYearEnd":"2021\/2\/28","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00944","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":8473,"settlementDate":null,"submitterName":"久光製薬株式会社","submitterNameEnglish":"HISAMITSU PHARMACEUTICAL CO.,INC.","submitterNameKana":"ヒサミツセイヤクカブシキガイシャ","location":"鳥栖市田代大官町４０８番地","industory":"医薬品","corporateNumber":7300000000000.0},{"edinetCode":"E00944","endDate":"2020\/8\/31","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":37319000.0,"sharesOwendPercent":0.4564,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.84,"cashAndCashEquivalents":95258000000.0,"assets":298939000000.0,"currentAssets":197445000000.0,"fixedAsset":101494000000.0,"tangibleFixedAssets":38147000000.0,"intangibleFixedAssets":1478000000.0,"investmentAndOtherAssets":61868000000.0,"liabilities":46033000000.0,"currentLiabilities":30714000000.0,"shorTermDept":1191000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":15318000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":326000000.0,"netAsset":252906000000.0,"capitalStock":230565000000.0,"capital":8473000000.0,"capitalSurplus":2352000000.0,"accumulatedEarnings":231232000000.0,"treasuryStock":-11493000000.0,"valuationAndConversionAdjustments":20667000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":52926000000.0,"costOfSales":19577000000.0,"grossProfit":33349000000.0,"sgaExpenses":27833000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":5240000000.0,"operatingIncome":5516000000.0,"nonOperatingIncome":1074000000.0,"nonOperatingExpenses":1071000000.0,"interestExpense":2000000.0,"ordinaryProfit":5519000000.0,"extraordinaryGain":1000000.0,"extraordinaryLoss":5000000.0,"incomeBeforeTax":5515000000.0,"incomeTaxes":1702000000.0,"netIncome":3813000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":3693000000.0,"comprehensiveIncome":5625000000.0,"eps":45.22,"dilutedEps":45.16,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":4156000000.0,"depreciationAndCashflowFromOperatingActivities":1934000000.0,"cashFlowFromInvestingActivities":8198000000.0,"cashFlowFromFinancialActivities":-3612000000.0,"changesInCashAndCashEquivalents":8261000000.0,"列1":"q2r","submitDate":"2020\/10\/9","stockCode":4530,"accountingYear":null,"accountingYearStart":"2020\/3\/1","accountingYearEnd":"2021\/2\/28","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00944","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":8473,"settlementDate":null,"submitterName":"久光製薬株式会社","submitterNameEnglish":"HISAMITSU PHARMACEUTICAL CO.,INC.","submitterNameKana":"ヒサミツセイヤクカブシキガイシャ","location":"鳥栖市田代大官町４０８番地","industory":"医薬品","corporateNumber":7300000000000.0},{"edinetCode":"E00944","endDate":"2020\/11\/30","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.84,"cashAndCashEquivalents":null,"assets":296548000000.0,"currentAssets":196460000000.0,"fixedAsset":100087000000.0,"tangibleFixedAssets":37151000000.0,"intangibleFixedAssets":1341000000.0,"investmentAndOtherAssets":61593000000.0,"liabilities":45806000000.0,"currentLiabilities":30256000000.0,"shorTermDept":1181000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":15550000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":309000000.0,"netAsset":250741000000.0,"capitalStock":229181000000.0,"capital":8473000000.0,"capitalSurplus":2352000000.0,"accumulatedEarnings":229848000000.0,"treasuryStock":-11493000000.0,"valuationAndConversionAdjustments":19883000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":80822000000.0,"costOfSales":30148000000.0,"grossProfit":50674000000.0,"sgaExpenses":42551000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":8123000000.0,"nonOperatingIncome":1467000000.0,"nonOperatingExpenses":1662000000.0,"interestExpense":5000000.0,"ordinaryProfit":7928000000.0,"extraordinaryGain":356000000.0,"extraordinaryLoss":21000000.0,"incomeBeforeTax":8263000000.0,"incomeTaxes":2409000000.0,"netIncome":5853000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":5722000000.0,"comprehensiveIncome":6865000000.0,"eps":70.04,"dilutedEps":69.97,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2021\/1\/14","stockCode":4530,"accountingYear":null,"accountingYearStart":"2020\/3\/1","accountingYearEnd":"2021\/2\/28","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00944","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":8473,"settlementDate":null,"submitterName":"久光製薬株式会社","submitterNameEnglish":"HISAMITSU PHARMACEUTICAL CO.,INC.","submitterNameKana":"ヒサミツセイヤクカブシキガイシャ","location":"鳥栖市田代大官町４０８番地","industory":"医薬品","corporateNumber":7300000000000.0},{"edinetCode":"E00944","endDate":"2021\/2\/28","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":2770.0,"averageTemporaryStaff":691.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":38166000.0,"sharesOwendPercent":0.4668,"outstandingShares":null,"numberOfSubsidiary":20.0,"bps":3083.98,"equityRatio":0.841,"cashAndCashEquivalents":91354000000.0,"assets":299861000000.0,"currentAssets":198061000000.0,"fixedAsset":101800000000.0,"tangibleFixedAssets":37354000000.0,"intangibleFixedAssets":1178000000.0,"investmentAndOtherAssets":63267000000.0,"liabilities":46051000000.0,"currentLiabilities":30057000000.0,"shorTermDept":1111000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":15994000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":296000000.0,"netAsset":253809000000.0,"capitalStock":232707000000.0,"capital":8473000000.0,"capitalSurplus":2352000000.0,"accumulatedEarnings":233376000000.0,"treasuryStock":-11495000000.0,"valuationAndConversionAdjustments":19359000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":114510000000.0,"costOfSales":45337000000.0,"grossProfit":69173000000.0,"sgaExpenses":58501000000.0,"salaryAndBenefit":7427000000.0,"depreciationAndSGA":null,"RDExpenses":10766000000.0,"operatingIncome":10671000000.0,"nonOperatingIncome":2061000000.0,"nonOperatingExpenses":903000000.0,"interestExpense":10000000.0,"ordinaryProfit":11829000000.0,"extraordinaryGain":408000000.0,"extraordinaryLoss":40000000.0,"incomeBeforeTax":12197000000.0,"incomeTaxes":2764000000.0,"netIncome":9433000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":9250000000.0,"comprehensiveIncome":9926000000.0,"eps":113.22,"dilutedEps":113.11,"dividendPerShare":null,"per":58.6,"roe":0.037,"cashFlowFromOperatingActivities":5289000000.0,"depreciationAndCashflowFromOperatingActivities":4079000000.0,"cashFlowFromInvestingActivities":7815000000.0,"cashFlowFromFinancialActivities":-7187000000.0,"changesInCashAndCashEquivalents":4357000000.0,"列1":"asr","submitDate":"2021\/5\/28","stockCode":4530,"accountingYear":"第119期(自　2020年３月１日　至　2021年２月28日)","accountingYearStart":"2020\/3\/1","accountingYearEnd":"2021\/2\/28","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00944","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":8473,"settlementDate":null,"submitterName":"久光製薬株式会社","submitterNameEnglish":"HISAMITSU PHARMACEUTICAL CO.,INC.","submitterNameKana":"ヒサミツセイヤクカブシキガイシャ","location":"鳥栖市田代大官町４０８番地","industory":"医薬品","corporateNumber":7300000000000.0},{"edinetCode":"E00944","endDate":"2021\/5\/31","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.849,"cashAndCashEquivalents":null,"assets":299904000000.0,"currentAssets":198804000000.0,"fixedAsset":101100000000.0,"tangibleFixedAssets":38460000000.0,"intangibleFixedAssets":1147000000.0,"investmentAndOtherAssets":61493000000.0,"liabilities":43415000000.0,"currentLiabilities":26837000000.0,"shorTermDept":1111000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":16578000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":273000000.0,"netAsset":256489000000.0,"capitalStock":231662000000.0,"capital":8473000000.0,"capitalSurplus":2352000000.0,"accumulatedEarnings":232331000000.0,"treasuryStock":-11496000000.0,"valuationAndConversionAdjustments":22995000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":27761000000.0,"costOfSales":11162000000.0,"grossProfit":16599000000.0,"sgaExpenses":14479000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":2120000000.0,"nonOperatingIncome":924000000.0,"nonOperatingExpenses":189000000.0,"interestExpense":1000000.0,"ordinaryProfit":2855000000.0,"extraordinaryGain":659000000.0,"extraordinaryLoss":29000000.0,"incomeBeforeTax":3485000000.0,"incomeTaxes":1050000000.0,"netIncome":2434000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":2362000000.0,"comprehensiveIncome":6070000000.0,"eps":28.91,"dilutedEps":28.89,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2021\/7\/9","stockCode":4530,"accountingYear":null,"accountingYearStart":"2021\/3\/1","accountingYearEnd":"2022\/2\/28","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00944","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":8473,"settlementDate":null,"submitterName":"久光製薬株式会社","submitterNameEnglish":"HISAMITSU PHARMACEUTICAL CO.,INC.","submitterNameKana":"ヒサミツセイヤクカブシキガイシャ","location":"鳥栖市田代大官町４０８番地","industory":"医薬品","corporateNumber":7300000000000.0},{"edinetCode":"E00944","endDate":"2021\/8\/31","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":37393000.0,"sharesOwendPercent":0.4573,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.836,"cashAndCashEquivalents":97395000000.0,"assets":309583000000.0,"currentAssets":206060000000.0,"fixedAsset":103522000000.0,"tangibleFixedAssets":38368000000.0,"intangibleFixedAssets":1503000000.0,"investmentAndOtherAssets":63651000000.0,"liabilities":49046000000.0,"currentLiabilities":31722000000.0,"shorTermDept":1111000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":17324000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":254000000.0,"netAsset":260536000000.0,"capitalStock":234317000000.0,"capital":8473000000.0,"capitalSurplus":2356000000.0,"accumulatedEarnings":234971000000.0,"treasuryStock":-11484000000.0,"valuationAndConversionAdjustments":24369000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":58551000000.0,"costOfSales":23120000000.0,"grossProfit":35430000000.0,"sgaExpenses":29723000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":5011000000.0,"operatingIncome":5706000000.0,"nonOperatingIncome":1356000000.0,"nonOperatingExpenses":226000000.0,"interestExpense":6000000.0,"ordinaryProfit":6836000000.0,"extraordinaryGain":659000000.0,"extraordinaryLoss":328000000.0,"incomeBeforeTax":7168000000.0,"incomeTaxes":2022000000.0,"netIncome":5145000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":5002000000.0,"comprehensiveIncome":10156000000.0,"eps":61.2,"dilutedEps":61.16,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":14663000000.0,"depreciationAndCashflowFromOperatingActivities":1974000000.0,"cashFlowFromInvestingActivities":-7164000000.0,"cashFlowFromFinancialActivities":-3572000000.0,"changesInCashAndCashEquivalents":6041000000.0,"列1":"q2r","submitDate":"2021\/10\/14","stockCode":4530,"accountingYear":null,"accountingYearStart":"2021\/3\/1","accountingYearEnd":"2022\/2\/28","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00944","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":8473,"settlementDate":null,"submitterName":"久光製薬株式会社","submitterNameEnglish":"HISAMITSU PHARMACEUTICAL CO.,INC.","submitterNameKana":"ヒサミツセイヤクカブシキガイシャ","location":"鳥栖市田代大官町４０８番地","industory":"医薬品","corporateNumber":7300000000000.0},{"edinetCode":"E00944","endDate":"2021\/11\/30","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.829,"cashAndCashEquivalents":null,"assets":303995000000.0,"currentAssets":203988000000.0,"fixedAsset":100007000000.0,"tangibleFixedAssets":38480000000.0,"intangibleFixedAssets":1397000000.0,"investmentAndOtherAssets":60128000000.0,"liabilities":50082000000.0,"currentLiabilities":34289000000.0,"shorTermDept":1111000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":15793000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":238000000.0,"netAsset":253913000000.0,"capitalStock":229674000000.0,"capital":8473000000.0,"capitalSurplus":2356000000.0,"accumulatedEarnings":232753000000.0,"treasuryStock":-13908000000.0,"valuationAndConversionAdjustments":22296000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":86663000000.0,"costOfSales":34884000000.0,"grossProfit":51779000000.0,"sgaExpenses":44805000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":6973000000.0,"nonOperatingIncome":1927000000.0,"nonOperatingExpenses":235000000.0,"interestExpense":11000000.0,"ordinaryProfit":8665000000.0,"extraordinaryGain":659000000.0,"extraordinaryLoss":333000000.0,"incomeBeforeTax":8992000000.0,"incomeTaxes":2564000000.0,"netIncome":6427000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":6218000000.0,"comprehensiveIncome":9349000000.0,"eps":76.14,"dilutedEps":76.09,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2022\/1\/14","stockCode":4530,"accountingYear":null,"accountingYearStart":"2021\/3\/1","accountingYearEnd":"2022\/2\/28","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00944","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":8473,"settlementDate":null,"submitterName":"久光製薬株式会社","submitterNameEnglish":"HISAMITSU PHARMACEUTICAL CO.,INC.","submitterNameKana":"ヒサミツセイヤクカブシキガイシャ","location":"鳥栖市田代大官町４０８番地","industory":"医薬品","corporateNumber":7300000000000.0}]